ArticleOncotarget2016
Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients.
Dawei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it